Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Revista
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Wounds ; 32(8): 208-216, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32804659

RESUMO

INTRODUCTION: Biofilm in chronic wounds impedes the wound healing process. Each biofilm has differing characteristics requiring a multifaceted approach for removal while maintaining a surrounding environment conducive to wound healing. OBJECTIVE: In this study, 3 of the components in a wound cleanser are tested to determine synergy in eradicating biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in vitro. MATERIALS AND METHODS: The 3 components assessed for synergy were ethylenediamine tetraacetic acid sodium salts (EDTA), vicinal diols (VD; ethylhexylglycerin and octane-1,2-diol), and polyhexamethylene biguanide (PHMB). Each component was assessed individually and in combination while dissolved in a base solution. The Calgary assay method was used for biofilm growth and treatment. Kull Equation analysis for synergy was conducted using viable count results. RESULTS: Synergy is defined as the interaction of components to produce a combined effect greater than the sum of their separate effects. The base solution containing all 3 components (EDTA, VD, and PHMB) reduced biofilm viability by more than 5 logs, demonstrating statistically significant synergy. The 3 components tested individually in the base solution resulted in the following: EDTA did not reduce bacteria viability; VD reduced viability by about 1 log; and PHMB reduced P aeruginosa viability by about 2.5 logs and MRSA viability by about 4 logs. Of importance, the MRSA biofilm failed to regrow in the recovery plates after combined treatment, indicating complete elimination of the biofilm bacteria. CONCLUSIONS: The experimental and calculated results indicate the 3 components (VD, EDTA, and PHMB) when used together act synergistically to eradicate MRSA and P aeruginosa biofilms in vitro.


Assuntos
Biguanidas/uso terapêutico , Biofilmes/efeitos dos fármacos , Detergentes/uso terapêutico , Ácido Edético/uso terapêutico , Éteres de Glicerila/uso terapêutico , Octanóis/uso terapêutico , Pele/efeitos dos fármacos , Ferimentos e Lesões/tratamento farmacológico , Biguanidas/administração & dosagem , Detergentes/administração & dosagem , Sinergismo Farmacológico , Ácido Edético/administração & dosagem , Éteres de Glicerila/administração & dosagem , Humanos , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Octanóis/administração & dosagem , Pseudomonas aeruginosa/efeitos dos fármacos , Pele/microbiologia , Ferimentos e Lesões/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA